A detailed history of Doliver Advisors, LP transactions in Johnson & Johnson stock. As of the latest transaction made, Doliver Advisors, LP holds 14,230 shares of JNJ stock, worth $2.36 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
14,230
Previous 15,130 5.95%
Holding current value
$2.36 Million
Previous $2.39 Million 13.12%
% of portfolio
0.6%
Previous 0.71%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$144.38 - $157.78 $129,942 - $142,002
-900 Reduced 5.95%
14,230 $2.08 Million
Q1 2024

Apr 12, 2024

SELL
$155.22 - $162.74 $41,443 - $43,451
-267 Reduced 1.73%
15,130 $2.39 Million
Q4 2023

Jan 03, 2024

SELL
$145.6 - $158.88 $97,843 - $106,767
-672 Reduced 4.18%
15,397 $2.41 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $8,410 - $9,421
-54 Reduced 0.33%
16,069 $2.5 Million
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $42,909 - $46,178
-278 Reduced 1.7%
16,123 $2.67 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $354,816 - $423,430
2,349 Added 16.72%
16,401 $2.54 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $21,627 - $24,271
-135 Reduced 0.95%
14,052 $2.48 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $1,935 - $2,154
-12 Reduced 0.08%
14,187 $2.32 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $763,582 - $844,485
4,540 Added 47.0%
14,199 $2.52 Million
Q4 2021

Feb 07, 2022

SELL
$155.93 - $173.01 $65,022 - $72,145
-417 Reduced 4.14%
9,659 $1.66 Million
Q3 2021

Nov 03, 2021

SELL
$161.5 - $179.47 $28,101 - $31,227
-174 Reduced 1.7%
10,076 $1.63 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $47,365 - $50,807
297 Added 2.98%
10,250 $1.69 Million
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $35,665 - $39,721
233 Added 2.4%
9,953 $1.64 Million
Q4 2020

Feb 04, 2021

BUY
$137.11 - $157.38 $123,399 - $141,642
900 Added 10.2%
9,720 $1.53 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $11,932 - $13,075
85 Added 0.97%
8,820 $1.31 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $48,947 - $59,093
380 Added 4.55%
8,735 $1.23 Million
Q1 2020

Apr 28, 2020

SELL
$111.14 - $153.99 $67,128 - $93,009
-604 Reduced 6.74%
8,355 $1.29 Million
Q4 2019

Jan 27, 2020

SELL
$127.5 - $146.44 $80,962 - $92,989
-635 Reduced 6.62%
8,959 $1.31 Million
Q3 2019

Nov 04, 2019

BUY
$126.95 - $142.14 $59,031 - $66,095
465 Added 5.09%
9,594 $1.27 Million
Q2 2019

Jul 25, 2019

BUY
$131.15 - $144.24 $8,787 - $9,664
67 Added 0.74%
9,129 $1.27 Million
Q1 2019

May 13, 2019

BUY
$125.72 - $139.79 $15,212 - $16,914
121 Added 1.35%
9,062 $1.27 Million
Q4 2018

Jan 31, 2019

SELL
$122.84 - $147.84 $189,787 - $228,412
-1,545 Reduced 14.73%
8,941 $1.15 Million
Q3 2018

Nov 02, 2018

BUY
$121.58 - $142.88 $20,911 - $24,575
172 Added 1.67%
10,486 $1.45 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $42,745 - $47,170
358 Added 3.6%
10,314 $1.25 Million
Q1 2018

May 08, 2018

BUY
$125.1 - $148.14 $345,276 - $408,866
2,760 Added 38.35%
9,956 $0
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $85,949 - $94,071
-655 Reduced 8.34%
7,196 $1.01 Million
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $1.02 Million - $1.06 Million
7,851
7,851 $1.02 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Doliver Advisors, LP Portfolio

Follow Doliver Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.